jrnl4160

Publication Venue For

  • Heatstroke.  381:1186. 2019
  • Oral selinexor-dexamethasone for triple-class refractory multiple myeloma.  381:727-738. 2019
  • Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.  381:432-443. 2019
  • Hazardous chemical emergencies and poisonings.  381:392. 2019
  • Rituximab or cyclosporine in the treatment of membranous nephropathy.  381:36-46. 2019
  • Weak and Winded.  381:76-82. 2019
  • Five-year outcomes of gastric bypass in adolescents as compared with adults.  380:2136-2145. 2019
  • Bag-mask ventilation during tracheal intubation of critically ill adults.  380:811-821. 2019
  • Organ donation and drug intoxication-related deaths in the United States.  380:597-599. 2019
  • Dapagliflozin and cardiovascular outcomes in type 2 diabetes.  380:347-357. 2019
  • Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL.  379:2517-2528. 2018
  • Sorafenib for advanced and refractory desmoid tumors.  379:2417-2428. 2018
  • Alirocumab and cardiovascular outcomes after acute coronary syndrome.  379:2097-2107. 2018
  • Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea.  379:1835-1845. 2018
  • Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis.  379:1621-1634. 2018
  • VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles.  379:1612-1620. 2018
  • VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles.  379:1599-1611. 2018
  • Abortion "reversal"-Legislating without evidence.  379:1491-1493. 2018
  • Cardiovascular safety of lorcaserin in overweight or obese patients.  379:1107-1117. 2018
  • Phase 2 trial of ibudilast in progressive multiple sclerosis.  379:846-855. 2018
  • Radical changes for reproductive health care - Proposed regulations for title X.  379:706-707. 2018
  • Labor induction versus expectant management in low-risk nulliparous women.  379:513-523. 2018
  • Procalcitonin-guided use of antibiotics for lower respiratory tract infection.  379:236-249. 2018
  • Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML.  378:2386-2398. 2018
  • Outpatient talc administration by indwelling pleural catheter for malignant effusion.  378:1313-1322. 2018
  • Cardiovascular safety of febuxostat or allopurinol in patients with gout.  378:1200-1210. 2018
  • Prosthesis type for aortic-and mitral-valve replacement.  378:776-777. 2018
  • Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.  378:195-196. 2018
  • Once-daily single-inhaler triple versus dual therapy in patients with COPD.  378:1671-1680. 2018
  • Tezacaftor–ivacaftor in residual-function heterozygotes with cystic fibrosis.  377:2024-2035. 2017
  • Romosozumab or alendronate for fracture prevention in women with osteoporosis.  377:1417-1427. 2017
  • Rivaroxaban with or without aspirin in stable cardiovascular disease.  377:1319-1330. 2017
  • Effects of anacetrapib in patients with atherosclerotic vascular disease.  377:1217-1227. 2017
  • Antiinflammatory therapy with canakinumab for atherosclerotic disease.  377:1119-1131. 2017
  • Cost-effectiveness of intensive versus standard blood-pressure control.  377:745-755. 2017
  • Effect of intensive blood-pressure treatment on patient-reported outcomes.  377:733-744. 2017
  • Subclinical hypothyroidism or hypothyroxinemia in pregnancy.  377:701. 2017
  • Health effects of overweight and obesity in 195 countries over 25 years.  377:13-27. 2017
  • KIT inhibition by imatinib in patients with severe refractory asthma.  376:1911-1920. 2017
  • Evolocumab and clinical outcomes in patients with cardiovascular disease.  376:1713-1722. 2017
  • Cardiovascular efficacy and safety of bococizumab in high-risk patients.  376:1527-1539. 2017
  • Dyskeratosis congenita.  376:1460. 2017
  • Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor..  376:1131-1140. 2017
  • Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy.  376:815-825. 2017
  • Survival and neurodevelopmental outcomes among periviable infants.  376:617-628. 2017
  • The authors reply.  376:598-599. 2017
  • The authors reply.  376:182. 2017
  • Permanent supportive housing for homeless people - Reframing the debate.  375:2115-2117. 2016
  • Effect of HIV antibody VRC01 on viral rebound after treatment interruption.  375:2037-2050. 2016
  • Acute pancreatitis.  375:1972-1981. 2016
  • The authors reply.  375:2006-2007. 2016
  • The authors reply.  375:1906. 2016
  • A randomized trial of long-term oxygen for COPD with moderate desaturation.  375:1617-1627. 2016
  • The authors reply.  375:e232. 2016
  • The authors reply.  375:1396. 2016
  • Medical Considerations before International Travel..  375:e32. 2016
  • Adjunctive azithromycin prophylaxis for cesarean delivery.  375:1231-1241. 2016
  • Genital herpes.  375:666-674. 2016
  • Randomized trial of thymectomy in myasthenia gravis.  375:511-522. 2016
  • Stenting versus surgery for carotid stenosis.  375:604-605. 2016
  • Management of Advanced Head and Neck Cancer.  375:492. 2016
  • The authors reply.  375:492-493. 2016
  • Medical considerations before international travel.  375:247-260. 2016
  • The authors reply.  375:288-289. 2016
  • Chemotherapy-induced nausea and vomiting.  375:177-179. 2016
  • Olanzapine for the prevention of chemotherapy-induced nausea and vomiting.  375:134-142. 2016
  • Patterns of growth and decline in lung function in Persistent Childhood Asthma.  374:1842-1852. 2016
  • Azithromycin versus Doxycycline for Chlamydia.  374:1787. 2016
  • Antenatal betamethasone for women at risk for late preterm delivery.  374:1311-1320. 2016
  • Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting.  374:1356-1367. 2016
  • Long-term results of stenting versus endarterectomy for carotid-artery stenosis.  374:1021-1031. 2016
  • Survival benefit with kidney transplants from HLA-incompatible live donors.  374:940-950. 2016
  • Reduction in late mortality among 5-year survivors of childhood cancer.  374:833-842. 2016
  • Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer.  374:738-748. 2016
  • Effects of testosterone treatment in older men.  374:611-624. 2016
  • Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.  374:113-123. 2016
  • Azithromycin versus doxycycline for urogenital chlamydia trachomatis infection.  373:2512-2521. 2015
  • Trial of continuous or interrupted chest compressions during CPR.  373:2203-2214. 2015
  • A randomized trial of intensive versus standard blood-pressure control.  373:2103-2116. 2015
  • Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1.  373:714-725. 2015
  • Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1.  373:705-713. 2015
  • A randomized trial of intrapartum fetal ECG ST-segment analysis.  373:632-641. 2015
  • Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR.  373:220-231. 2015
  • Fibrosis--A Common Pathway to Organ Injury and Failure.  373:96. 2015
  • Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas.  372:2481-2498. 2015
  • Ezetimibe added to statin therapy after acute coronary syndromes.  372:2387-2397. 2015
  • Less-tight versus tight control of hypertension in pregnancy.  372:2366-2367. 2015
  • Less-tight versus tight control of hypertension in pregnancy.  372:2366-2368. 2015
  • A longitudinal study of bullying of sexual-minority youth.  372:1872-1874. 2015
  • Between-hospital variation in treatment and outcomes in extremely preterm infants.  372:1801-1811. 2015
  • A history lesson.  372:1360-1364. 2015
  • Fibrosis-a common pathway to organ injury and failure.  372:1138-1149. 2015
  • Why is there no generic insulin? historical origins of a modern problem.  372:1171-1175. 2015
  • Valganciclovir for symptomatic congenital cytomegalovirus disease.  372:933-943. 2015
  • Smoking and Mortality-Beyond Established Causes.  372:631-640. 2015
  • Preventing HIV in women - Still trying to find their voice.  372:564-566. 2015
  • Preventing HIV in women--still trying to find their VOICE.  372:564-566. 2015
  • Tenofovir-based preexposure prophylaxis for HIV infection among African women.  372:509-518. 2015
  • Causes and timing of death in extremely premature infants from 2000 through 2011.  372:331-340. 2015
  • The authors reply.  372:2463. 2015
  • Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.  371:1005-1015. 2014
  • Low sodium intake - Cardiovascular health benefit or risk?.  371:677-679. 2014
  • Transplantation of Severe Combined Immunodeficiency in 240 Patients from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America..  371:434--446. 2014
  • A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.  372:711-723. 2014
  • A controlled trial of renal denervation for resistant hypertension.  370:1393-1401. 2014
  • A novel potential therapy for HSV.  370:273-274. 2014
  • Oral GS-5806 activity in a respiratory syncytial virus challenge study.  371:711-722. 2014
  • Prenatal whole-genome sequencing - Is the quest to know a fetus's future ethical?.  370:195-197. 2014
  • Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.  370:2093-2101. 2014
  • Secukinumab in plaque psoriasis - Results of two phase 3 trials.  371:326-338. 2014
  • Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.  370:2201-2210. 2014
  • Fungal infections associated with contaminated methylprednisolone injections..  369:1598-1609. 2013
  • Results of the Two Incidence Screenings in the National Lung Screening Trial.  369:920-931. 2013
  • Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis.  369:699-710. 2013
  • The authors reply.  368:2236-2237. 2013
  • Oxygen-saturation targets in extremely preterm infants.  368:1949-1950. 2013
  • Continuous renal-replacement therapy for acute kidney injury..  368:1160-1161. 2013
  • Myths, presumptions, and facts about obesity.  368:446-454. 2013
  • A pharmacogenetic versus a clinical algorithm for warfarin dosing.  369:2283-2293. 2013
  • Abatacept in B7-1-positive proteinuric kidney disease.  369:2416-2423. 2013
  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.  369:2492-2503. 2013
  • Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.  369:145-154. 2013
  • Edoxaban versus warfarin in patients with atrial fibrillation.  369:2093-2104. 2013
  • Fungal infections associated with contaminated methylprednisolone injections.  368:2495-2500. 2013
  • Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.  369:1691-1703. 2013
  • MEdical progress: IgA nephropathy.  368:2402-2414. 2013
  • Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.  369:517-528. 2013
  • The authors reply.  369:2358-2359. 2013
  • Continuous renal-replacement therapy for acute kidney injury.  367:2505-2514. 2012
  • Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.  367:2495-2504. 2012
  • The authors reply.  367:2254-2255. 2012
  • Anticholinergic therapy vs. onabotulinumtoxinA for urgency urinary incontinence.  367:1803-1813. 2012
  • Linezolid for treatment of chronic extensively drug-resistant tuberculosis..  367:1508-1518. 2012
  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.  367:1297-1309. 2012
  • Cutting family planning in Texas.  367:1179-1181. 2012
  • Pulmonary arterial enlargement and acute exacerbations of COPD.  367:913-921. 2012
  • Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.  367:817-825. 2012
  • Racial and ethnic health disparities among fifth-graders in three cities.  367:735-745. 2012
  • A midurethral sling to reduce incontinence after vaginal prolapse repair.  366:2358-2367. 2012
  • Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.  366:2345-2357. 2012
  • A randomized trial of urodynamic testing before stress-incontinence surgery.  366:1987-1997. 2012
  • Vorapaxar in the secondary prevention of atherothrombotic events.  366:1404-1413. 2012
  • Industry Support of CME - Are we at the tipping point?.  366:1069-1071. 2012
  • Intramuscular versus intravenous therapy for prehospital status epilepticus..  366:591-600. 2012
  • The authors reply.  366:90-91. 2012
  • Incorporation of bevacizumab in the primary treatment of ovarian cancer.  365:2473-2483. 2011
  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.  365:1663-1672. 2011
  • Constrictive bronchiolitis in soldiers [1].  365:1743-1745. 2011
  • Inducible apoptosis as a safety switch for adoptive cell therapy.  365:1673-1683. 2011
  • The authors reply.  365:1746-1747. 2011
  • Oral acyclovir suppression and neurodevelopment after neonatal herpes.  365:1284-1292. 2011
  • Stenting versus aggressive medical therapy for intracranial arterial stenosis.  365:993-1003. 2011
  • A Trial of an Impedance Threshold Device in Out-of-Hospital Cardiac Arrest.  365:798-806. 2011
  • Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest.  365:787-797. 2011
  • Azithromycin for prevention of exacerbations of COPD.  365:689-698. 2011
  • The authors reply.  365:671-672. 2011
  • Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening.  365:395-409. 2011
  • Bardoxolone methyl and kidney function in CKD with type 2 diabetes.  365:327-336. 2011
  • Desensitization in HLA-incompatible kidney recipients and survival.  365:318-326. 2011
  • The authors reply.  365:277-278. 2011
  • Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.  364:2111-2118. 2011
  • gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.  364:2119-2127. 2011
  • Abiraterone and increased survival in metastatic prostate cancer.  364:1995-2005. 2011
  • Alemtuzumab induction in renal transplantation.  364:1909-1919. 2011
  • Dialysis catheters and recombinant tissue plasminogen activator.  364:1779-1780. 2011
  • NFKBIA deletion in glioblastomas.  364:627-637. 2011
  • In search of....  363:2249-2254. 2010
  • Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.  363:1991-2003. 2010
  • The origin of ovarian cancer - Is it getting clearer?.  363:1574-1575. 2010
  • The authors reply.  363:1285-1286. 2010
  • A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.  363:620-628. 2010
  • Stenting versus endarterectomy for treatment of carotid-artery stenosis.  363:11-23. 2010
  • The authors reply.  362:2428. 2010
  • Retropubic versus Transobturator Midurethral Slings for Stress Incontinence.  362:2066-2076. 2010
  • Early CPAP versus surfactant in extremely preterm infants.  362:1970-1979. 2010
  • Target ranges of oxygen saturation in extremely preterm infants.  362:1959-1969. 2010
  • Stent graft or balloon angioplasty alone for dialysis-access grafts [6].  362:1939. 2010
  • Vitamins C and E to prevent complications of pregnancy-associated hypertension.  362:1282-1291. 2010
  • Newborn-care training and perinatal mortality in developing countries.  362:614-623. 2010
  • Gene therapy for color blindness.  361:2483. 2009
  • Functional status of elderly adults before and after initiation of dialysis.  361:1539-1547. 2009
  • A multicenter, randomized trial of treatment for mild gestational diabetes.  361:1339-1348. 2009
  • A weighty matter - Lifting after breast cancer.  361:710-711. 2009
  • C3 polymorphisms and outcomes of renal allografts.  360:2477-2479. 2009
  • Medicare nonpayment, hospital falls, and unintended consequences.  360:2390-2393. 2009
  • Effect of dipyridamole plus aspirin on hemodialysis graft patency.  360:2191-2201. 2009
  • Effect of early versus deferred antiretroviral therapy for HIV on survival.  360:1815-1826. 2009
  • Efficacy of esomeprazole for treatment of poorly controlled asthma.  360:1487-1499. 2009
  • The authors reply.  360:1570-1571. 2009
  • Mortality results from a randomized prostate-cancer screening trial.  360:1310-1319. 2009
  • Racial differences in incident heart failure among young adults.  360:1179-1190. 2009
  • Vaccine prevention of maternal cytomegalovirus infection.  360:1191-1199. 2009
  • Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data.  360:753-764. 2009
  • Letter to the editors.  360:540-541. 2009
  • Weight loss to treat urinary incontinence in overweight and obese women.  360:481-490. 2009
  • The neurontin legacy - Marketing through misinformation and manipulation.  360:103-106. 2009
  • Timing of elective repeat cesarean delivery at term and neonatal outcomes.  360:111-120. 2009
  • Dicer, Drosha, and outcomes in patients with ovarian cancer.  359:2641-2650. 2008
  • The author replies.  359:2293-2294. 2008
  • Aggressive vs. conservative phototherapy for infants with extremely low birth weight.  359:1885-1896. 2008
  • Medical progress: Uric acid and cardiovascular risk.  359:1811-1821. 2008
  • Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection.  359:1442-1455. 2008
  • Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.  359:584-592. 2008
  • Malaria prevention in short-term travelers.  359:603-612. 2008
  • Safety and efficacy of gene transfer for Leber's congenital amaurosis.  358:2240-2248. 2008
  • Hyperglycemia and adverse pregnancy outcomes.  358:1991-2002. 2008
  • MicroRNA expression in cytogenetically normal acute myeloid leukemia.  358:1919-1928. 2008
  • The authors reply.  358:1303-1304. 2008
  • The new age of molecular diagnostics for microbial agents.  358:988-989. 2008
  • Incidental findings on brain MRI [7].  358:853-855. 2008
  • Association between microdeletion and microduplication at 16p11.2 and autism.  358:667-675. 2008
  • Focus on research: Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina.  358:552-554. 2008
  • Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.  357:2237-2247. 2007
  • Mirror therapy for phantom limb pain [15].  357:2206-2207. 2007
  • The authors reply [8].  357:2202-2203. 2007
  • Teriparatide or alendronate in glucocorticoid-induced osteoporosis.  357:2028-2039. 2007
  • More on severe cutaneous reaction with radiotherapy and cetuximab [13].  357:1872-1873. 2007
  • HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.  357:1301-1310. 2007
  • The tension between needing to improve care and knowing how to do it.  357:608-613. 2007
  • Weekend admission for myocardial infarction [11].  357:87. 2007
  • Anidulafungin versus fluconazole for invasive candidiasis.  356:2472-2482. 2007
  • Burch colposuspension versus fascial sling to reduce urinary stress incontinence.  356:2143-2155. 2007
  • Long-Term Effect of Diabetes and Its Treatment on Cognitive Function.  356:1842-1852. 2007
  • Retinal progenitor cells - Timing is everything.  356:1577-1579. 2007
  • Influence of computer-aided detection on performance of screening mammography.  356:1399-1409. 2007
  • Varicella-zoster vaccine for the prevention of herpes zoster.  356:1338-1343. 2007
  • Effect of ramipril on the incidence of diabetes.  355:1551-1562. 2006
  • The authors reply [8].  355:1176. 2006
  • Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure.  355:354-364. 2006
  • The authors and a colleague reply [11].  354:2187. 2006
  • The authors reply [13].  354:1851. 2006
  • Feasibility of treating prehypertension with an angiotensin-receptor blocker.  354:1685-1697. 2006
  • Abdominal sacrocolpopexy with burch colposuspension to reduce urinary stress incontinence.  354:1557-1566. 2006
  • Calcium plus vitamin D supplementation and the risk of colorectal cancer.  354:684-696. 2006
  • Calcium plus vitamin D supplementation and the risk of fractures.  354:669-683. 2006
  • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.  354:567-578. 2006
  • Spectrum of disease and relation to place of exposure among ill returned travelers.  354:119-130. 2006
  • The authors reply [2].  354:202-203. 2006
  • Molecular identification of bacteria associated with bacterial vaginosis.  353:1899-1911. 2005
  • Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.  353:1574-1584. 2005
  • Autoantibody signatures in prostate cancer.  353:1224-1235. 2005
  • Inhaled nitric oxide for premature infants with severe respiratory failure.  353:13-22. 2005
  • Cystic fibrosis.  352:2039. 2005
  • Cystic fibrosis.  352:1992-2001. 2005
  • Case 13-2005: A 48-year-old man with weakness of the limbs and multiple tumors of spinal nerves.  352:1800-1808. 2005
  • Azithromycin for the secondary prevention of coronary events.  352:1637-1645. 2005
  • Rivastigmine for dementia associated with Parkinson's disease..  352:1387. 2005
  • Personal digital educators.  352:860-862. 2005
  • U.K. controlled trial of intrapleural streptokinase for pleural infection.  352:865-874. 2005
  • Anti-interleukin-12 antibody for active Crohn's disease [3] (multiple letters).  352:627-628. 2005
  • Glycogen storage diseases presenting as hypertrophic cardiomyopathy.  352:362-372. 2005
  • Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery.  351:2581-2589. 2004
  • Levodopa and the progression of parkinson’s disease.  351:2498-2508. 2004
  • Hyperkalemia after the Publication of RALES [1] (multiple letters).  351:2448-2450. 2004
  • Anti-interleukin-12 antibody for active Crohn's disease.  351:2069-2079. 2004
  • Syphilis control - A continuing challenge.  351:122-124. 2004
  • Genital Herpes.  350:1970-1977+2017. 2004
  • Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.  350:1850-1861. 2004
  • Clinical practice. Genital herpes..  350:1970-1977. 2004
  • Transient Memory Impairment and Hallucinations Associated with Tolterodine Use [8].  349:2274-2275. 2003
  • The Rapid Development of Fluoroquinolone Resistance in M. tuberculosis [7].  349:1977-1978. 2003
  • Gentamicin-induced correction of CFTR, function in patients with cystic fibrosis and CFTR stop mutations.  349:1433-1441. 2003
  • Low-carbohydrate diets as compared with low-fat diets [2] (multiple letters).  349:1000-1002. 2003
  • Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.  348:2379-2385. 2003
  • Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus.  348:2294-2303. 2003
  • A randomized trial of a low-carbohydrate diet for obesity.  348:2082-2090. 2003
  • Herpes zoster [8] (multiple letters).  348:2044-2045. 2003
  • Effect of dialysis dose and membrane flux in maintenance hemodialysis.  347:2010-2019. 2002
  • Herpes zoster.  347:340-346. 2002
  • Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants.  347:240-247. 2002
  • Voriconazole versus liposomal amphotericin B for empirical antifungal therapy [1] (multiple letters).  346:1745-1747. 2002
  • Genes, microbes, and T cells - New therapeutic targets in Crohn's disease.  346:614-616. 2002
  • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.  346:225-234. 2002
  • A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.  345:1444-1451. 2001
  • Long-term use of a left ventricular assist device for end-stage heart failure.  345:1435-1443. 2001
  • Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.  345:487-493. 2001
  • Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I [1] letters).  345:64-66. 2001
  • Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.  344:1366-1371. 2001
  • The continuing value of the Apgar score for the assessment of newborn infants.  344:467-471. 2001
  • Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I.  344:270-274. 2001
  • Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.  344:95-101. 2001
  • Renal transplantation in black Americans.  343:1545-1552. 2000
  • Stroke in patients with asymptomatic internal-carotid-artery stenosis.  343:1420-1420. 2000
  • The volume of primary angioplasty procedures and survival after acute myocardial infarction [4] (multiple letters).  343:1045. 2000
  • Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.  343:522-529. 2000
  • Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.  343:246-253. 2000
  • The volume of primary angioplasty procedures and survival after acute myocardial infarction.  342:1573-1580. 2000
  • Intrauterine infection and preterm delivery.  342:1500-1507. 2000
  • Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.  342:998-1006. 2000
  • Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms.  342:829-835. 2000
  • Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis.  342:534-540. 2000
  • Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin [1] (multiple letters).  341:762-763. 1999
  • Vitamin A supplementation for extremely-low-birth-weight infants.  340:1962-1968. 1999
  • Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist [4] (multiple letters).  340:1926-1928. 1999
  • Acute necrotizing pancreatitis.  340:1412-1417. 1999
  • Birth weight in relation to morbidity and mortality among newborn infants.  340:1234-1238. 1999
  • Mechanisms of Disease: Genetic disorders of renal electrolyte transport.  340:1177-1187. 1999
  • Cytomegalovirus retinitis - Evolving therapies in a new era.  340:1109-1110. 1999
  • Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia.  340:764-771. 1999
  • Reduction of cisplatin-induced emesis by a selective neurokinin-1- receptor antagonist.  340:190-195. 1999
  • A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.  339:1810-1816. 1998
  • Human cloning [5] (multiple letters).  339:1558-1559. 1998
  • Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension.  339:667-671. 1998
  • Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.  339:444-449. 1998
  • Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis.  339:292-299. 1998
  • Low-dose aspirin to prevent preeclampsia in women at high risk.  338:701-705. 1998
  • Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation.  338:161-165. 1998
  • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.  337:1576-1583. 1997
  • Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.  337:141-147. 1997
  • Trial of calcium to prevent preeclampsia.  337:69-76. 1997
  • Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.  337:15-21. 1997
  • Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery.  336:92-99. 1997
  • Erratum: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome (New England Journal of Medicine (1997) 337 (15-21)).  337:1557-1558. 1997
  • Current concepts: Evaluation of dementia.  335:330-336. 1996
  • Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI) investigators.  335:217-225. 1996
  • Bacterial vaginosis and preterm birth [3].  334:1337-1339. 1996
  • Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.  334:1023-1028. 1996
  • Breast cancer and other second neoplasms after childhood Hodgkin's disease.  334:745-751. 1996
  • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.  334:296-300. 1996
  • Late effects of treatment for childhood Hodgkin's disease [3].  335:352-355. 1996
  • Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.  333:1732-1736. 1995
  • A preliminary study of ritonavir, an inhibitor of hiv-1 protease, to treat hiv-1 infection.  333:1534-1540. 1995
  • A controlled study of adenoviral-vector–mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.  333:823-831. 1995
  • Long-term treatment of osteopetrosis with recombinant human interferon gamma.  332:1594-1599. 1995
  • Regeneration of t cells after chemotherapy.  332:1650-1652. 1995
  • Molecular diagnosis.  332:1499-1502. 1995
  • A randomized trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients.  332:1338-1344. 1995
  • Hypertensive crisis since fdr – a partial victory.  332:1029-1030. 1995
  • Coronary angioplasty compared with bypass grafting.  332:888-890. 1995
  • Coronary angioplasty compared with bypass grafting..  332:889. 1995
  • HLA matching in renal transplantation.  332:752-753. 1995
  • Molecular medicine molecular diagnosis.  332:1218-1221. 1995
  • Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke.  331:1474-1479. 1994
  • A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia.  331:1325-1330. 1994
  • Hormonal treatment of postmenopausal women.  331:550. 1994
  • Performance of four computer-based diagnostic systems.  330:1792-1796. 1994
  • A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants.  330:1107-1113. 1994
  • What to do when zidovudine fails.  330:706-707. 1994
  • Liddle's Syndrome Revisited – A Disorder of Sodium Reabsorption in the Distal Tubule.  330:178-181. 1994
  • A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.  329:1065-1072. 1993
  • Medicaid Coverage of Oral Rehydration Solutions.  329:211. 1993
  • The Affliction of Internal Medicine.  329:212. 1993
  • The Spring Meetings – Are They Dying?.  328:1645-1647. 1993
  • Antihypertensive Therapy – Efficacy and Quality of Life.  328:959-961. 1993
  • A Controlled Clinical Trial of Dichloroacetate for Treatment of Lactic Acidosis in Adults.  327:1564-1569. 1992
  • Acquired Syphilis in Adults.  327:959-961. 1992
  • Acyclovir: A Decade Later.  327:782-789. 1992
  • Where Have All the Primary Care Applicants Gone?.  326:1778-1780. 1992
  • Acyclovir in chickenpox.  326:1224-1226. 1992
  • Home monitoring of uterine activity.  326:1222-1224. 1992
  • Acquired syphilis in adults.  326:1060-1069. 1992
  • A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group..  326:793-798. 1992
  • A controlled trial of fluconazole or amphotericin b to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.  326:793-798. 1992
  • The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.  326:663-667. 1992
  • Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates.  326:161-166. 1992
  • Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group..  326:83-89. 1992
  • Comparison of amphotericin b with fluconazole in the treatment of acute aids-associated cryptococcal meningitis.  326:83-89. 1992
  • Drug promotion and scientific exchange.  326:133-134. 1992
  • Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels.  325:1630-1634. 1991
  • A Controlled Trial of Acyclovir for Chickenpox in Normal Children.  325:1539-1544. 1991
  • A Comparison of Single-Dose Cefixime with Ceftriaxone as Treatment for Uncomplicated Gonorrhea.  325:1337-1341. 1991
  • Does It Prevent Prematurity?.  325:1374-1377. 1991
  • Primary hiv-1 infection.  325:733-735. 1991
  • Rapid loss of vertebral mineral density after renal transplantation.  325:544-550. 1991
  • Higgledy, piggledy?.  325:361-362. 1991
  • A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants.  324:1005-1011. 1991
  • High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.  324:954-960. 1991
  • Treatment of hypertensive crisis.  324:992-994. 1991
  • A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection.  324:444-449. 1991
  • Predictors of morbidity and mortality in neonates with herpes simplex virus infections.  324:450-454. 1991
  • Higgledy, piggledy.  324:497. 1991
  • Cyclical etidronate treatment of osteoporosis.  323:1633-1635. 1990
  • Treatment of hypertensive crisis.  323:1177-1183. 1990
  • Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis.  323:996-998. 1990
  • Viral Encephalitis.  323:242-250. 1990
  • A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis.  322:1189-1194. 1990
  • Aerosolized amiloride for the treatment of lung disease in cystic fibrosis (Reply).  323:997-998. 1990
  • Hypertension, Race, and Renal Insufficiency.  321:690-692. 1989
  • Adrenal Medullary Autografts in Patients with Parkinson's Disease.  321:324-327. 1989
  • Nosocomial Clostridium difficile Infections.  321:190. 1989
  • Two Plans for Universal Health Insurance.  321:114-119. 1989
  • The Hook Effect: High Concentrations of Prostate-Specific Antigen Giving Artifactually Low Values on One-Step Immunoassay.  320:1755-1756. 1989
  • A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at Birth.  320:1511-1516. 1989
  • Pressure Ulcers among the Elderly.  320:850-853. 1989
  • Renal Insufficiency in Treated Essential Hypertension.  320:684-688. 1989
  • Right Renal Trauma: A Side Effect of Biliary Lithotripsy.  320:739. 1989
  • Valvular Heart Disease in Systemic Lupus Erythematosus.  320:739-741. 1989
  • Cerebral Cavernous Malformations.  319:1414-1415. 1988
  • Diagnostic Yield of the Autopsy.  319:1095-1096. 1988
  • The Mortality Experience of Major-League Baseball Players.  319:1014-1015. 1988
  • Predictive Testing for Huntington's Disease Using Linked DNA Markers.  319:583-584. 1988
  • Cerebral Cavernous Malformations.  319:343-347. 1988
  • Falsification of Credentials by Applicants for Medical Staffs.  319:376-377. 1988
  • Screening for HIV Infection in Sexually Transmitted Disease Clinics.  319:242-243. 1988
  • Sonographic Identification of Down's Syndrome.  318:1399-1400. 1988
  • Diagnostic Yield of the Autopsy in a University Hospital and a Community Hospital.  318:1249-1254. 1988
  • The Mortality Experience of Major-League Baseball Players.  318:1278-1280. 1988
  • Thin Stage I Primary Cutaneous Malignant Melanoma.  318:1159-1162. 1988
  • Predictive Testing for Huntingtons Disease with Use of a Linked DNA Marker.  318:535-542. 1988
  • Human Immunodeficiency Virus Infection among Patients Attending Clinics for Sexually Transmitted Diseases.  318:197-203. 1988
  • Young Children as a Probable Source of Maternal and Congenital Cytomegalovirus Infection.  317:1539-1540. 1987
  • An ACTH Receptor on Human Mononuclear Leukocytes.  317:1266-1269. 1987
  • Chronic Recurrent Multifocal Osteomyelitis: Are Mycoplasmas Involved?.  317:510-511. 1987
  • Prolactin Levels after Pregnancy.  317:384-386. 1987
  • Young Children as a Probable Source of Maternal and Congenital Cytomegalovirus Infection.  316:1366-1370. 1987
  • The Case for the Use of Animals in Biomedical Research.  316:551-553. 1987
  • Hemophilus Influenzae Type B Disease in Children Vaccinated with Type B Polysaccharide Vaccine.  315:1584-1590. 1986
  • Hematologic Data in the Case Records.  315:1488-1489. 1986
  • Herpesvirus Infections of Pregnancy.  314:1255. 1986
  • Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody.  314:1236-1239. 1986
  • Biogenic Amines in the Rett Syndrome.  314:784. 1986
  • Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence.  314:403-408. 1986
  • Methyldopa and Reticuloendothelial Function.  314:248-249. 1986
  • Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis.  314:144-149. 1986
  • Asymptomatic Blood Donor with a False Positive HTLV-III Western Blot.  314:118. 1986
  • Lymphomatous All with Abnormalities of the Short Arm of Chromosome 9.  313:1611-1612. 1985
  • Herpesvirus Infections of Pregnancy: Herpes Simplex Virus and Varicella–Zoster Virus Infections.  313:1327-1330. 1985
  • Herpesvirus Infections of Pregnancy: Cytomegalovirus and Epstein–Barr Virus Infections.  313:1270-1274. 1985
  • Reduction of Biogenic Amine Levels in the Rett Syndrome.  313:921-924. 1985
  • Familial IgA Nephropathy.  313:186. 1985
  • Parvovirus Infection: Chance and Investigation.  313:111-112. 1985
  • Familial IgA Nephropathy: Evidence of an Inherited Mechanism of Disease.  312:202-208. 1985
  • Clonal Remission in Acute Leukemia.  311:922-923. 1984
  • Oral Levodopa in Heart Failure.  311:671-672. 1984
  • Predicting Relapse in Acute Asthma.  311:197-198. 1984
  • Treatment of Herpesvirus Infections.  310:654-655. 1984
  • Inability to Predict Relapse in Acute Asthma.  310:577-580. 1984
  • Teaching Clinical Medicine by Iterative Hypothesis Testing.  310:600-601. 1984
  • Percutaneous Transluminal Renal Angioplasty in Renovascular Hypertension.  310:322-323. 1984
  • B-Cell Abnormalities in AIDS.  310:258-259. 1984
  • Percutaneous Transluminal Renal Angioplasty in Renovascular Hypertension Due to Atheroma or Fibromuscular Dysplasia.  309:274-279. 1983
  • Caring for Other Physicians.  308:1542-1543. 1983
  • End-Stage Renal Disease in Systemic Lupus Erythematosus.  308:1537-1539. 1983
  • Microbiologic Study of Infertile Women at the Time of Diagnostic Laparoscopy: Association of Ureaplasma Urealyticum with a Defined Subpopulation.  308:502-505. 1983
  • Vidarabine for Herpes Zoster.  308:526-527. 1983
  • Effect of ABO Blood-Group Antigens on Long-Term Survival after Cardiac Transplantation.  307:1275-1276. 1982
  • DNA Restriction-Enzyme Analysis of Herpes Simplex Virus Isolates Obtained from Patients with Encephalitis.  307:1060-1062. 1982
  • Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed Patients.  307:971-975. 1982
  • False-Negative Results with Levodopa for Early Detection of Huntington's Disease.  307:561-562. 1982
  • Racial Differences in the Incidence of Treatment for End-Stage Renal Disease.  306:1276-1279. 1982
  • Routine Endoscopy in Upper-Gastrointestinal Tract Bleeding.  306:869-871. 1982
  • Properdin Deficiency with IgA Nephropathy.  305:1097. 1981
  • Correlation of Spectral Phonoangiography and Carotid Angiography with Gross Pathology in Carotid Stenosis.  305:417-419. 1981
  • Herpes Simplex Encephalitis.  304:1236-1237. 1981
  • Herpes Simplex Encephalitis: Vidarabine Therapy and Diagnostic Problems.  304:313-318. 1981
  • Operative Risk Factors in Patients with Left Main Coronary-Artery Disease.  303:953-957. 1980
  • Cimetidine for Prevention of Acute Gastrointestinal Bleeding.  303:108-110. 1980
  • HLA in Juvenile Diabetes.  302:405-406. 1980
  • Treatment of Hyperuricemia and Gout.  301:1240-1241. 1979
  • Preanesthetic Management of the Hypertensive Patient.  301:942. 1979
  • Fc-receptor dysfunction in lupus..  300:1487. 1979
  • Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus.  300:518-523. 1979
  • Treatment of Lupus Nephritis with Combined Therapy.  300:564-565. 1979
  • Fetal Bladder-Neck Obstruction and Elevated Amniotic-Fluid Alpha Fetoprotein.  297:1351. 1977
  • Ara-A for Herpes Encephalitis.  297:1288-1290. 1977
  • Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study.  297:289-294. 1977
  • Evaluation of Tetracycline or Penicillin and Ampicillin for Treatment of Acute Pelvic Inflammatory Disease.  296:1380-1383. 1977
  • Aspirin and Renal Function.  296:1168-1169. 1977
  • Aspirin-Induced Depression of Renal Function.  296:418-424. 1977
  • CT-Scan Symbols.  295:1262. 1976
  • Vinblastine or Vincristine?.  295:677. 1976
  • Adenine Arabinoside Therapy of Herpes Zoster in the Immunosuppressed: NIAID Collaborative Antiviral Study.  294:1193-1199. 1976
  • Fixation of I.V. Catheters.  291:1309-1310. 1974
  • The Renin-Angiotensin System.  291:446-457. 1974
  • The Renin-Angiotensin System.  291:389-401. 1974
  • The renin-angiotensin system (first of two parts)..  291:389-401. 1974
  • Estrogen Binding in Breast Cancer.  290:914. 1974
  • Left-Superior-Vena-Cava Steal Syndrome.  286:303-304. 1972
  • Carbenicillin — Gentamicin.  285:411-412. 1971
  • Pathogenesis of hyperuricemia in saturinine gout..  280:1199-1202. 1969
  • Primary cutaneous tuberculosis resulting from mouth-to-mouth respiration..  273:1035-1036. 1965
  • Vedolizumab as induction and maintenance therapy for Crohn's disease.  369:711-721.